These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25052233)

  • 1. Human uridine phosphorylase-1 inhibitors: a new approach to ameliorate 5-fluorouracil-induced intestinal mucositis.
    Renck D; Santos AA; Machado P; Petersen GO; Lopes TG; Santos DS; Campos MM; Basso LA
    Invest New Drugs; 2014 Dec; 32(6):1301-7. PubMed ID: 25052233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effects of Aquilariae Lignum Resinatum extract on 5-Fuorouracil-induced intestinal mucositis in mice.
    Zheng H; Gao J; Man S; Zhang J; Jin Z; Gao W
    Phytomedicine; 2019 Feb; 54():308-317. PubMed ID: 30396718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice.
    Hamouda N; Sano T; Oikawa Y; Ozaki T; Shimakawa M; Matsumoto K; Amagase K; Higuchi K; Kato S
    Basic Clin Pharmacol Toxicol; 2017 Sep; 121(3):159-168. PubMed ID: 28374966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
    Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
    Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.
    Wu ZQ; Han XD; Wang Y; Yuan KL; Jin ZM; Di JZ; Yan J; Pan Y; Zhang P; Huang XY; Wang ZG; Zheng Q
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):87-96. PubMed ID: 20844880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.
    Azevedo OG; Oliveira RA; Oliveira BC; Zaja-Milatovic S; Araújo CV; Wong DV; Costa TB; Lucena HB; Lima RC; Ribeiro RA; Warren CA; Lima AÂ; Vitek MP; Guerrant RL; Oriá RB
    BMC Gastroenterol; 2012 Jul; 12():35. PubMed ID: 22524518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis.
    Kissow H; Hartmann B; Holst JJ; Poulsen SS
    Gut; 2013 Dec; 62(12):1724-33. PubMed ID: 23086829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.
    Yasuda M; Kato S; Yamanaka N; Iimori M; Matsumoto K; Utsumi D; Kitahara Y; Amagase K; Horie S; Takeuchi K
    Br J Pharmacol; 2013 Mar; 168(6):1388-400. PubMed ID: 23072534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis.
    Torres DM; Tooley KL; Butler RN; Smith CL; Geier MS; Howarth GS
    Cancer Biol Ther; 2008 Feb; 7(2):295-302. PubMed ID: 18059190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of cystine and theanine attenuates 5-fluorouracil-induced intestinal mucositis and diarrhea by suppressing both glutathione level decrease and ROS production in the small intestine of mucositis mouse model.
    Yoneda J; Nishikawa S; Kurihara S
    BMC Cancer; 2021 Dec; 21(1):1343. PubMed ID: 34922485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Rutin in 5-Fluorouracil-Induced Intestinal Mucositis: Prevention of Histological Damage and Reduction of Inflammation and Oxidative Stress.
    Fideles LS; de Miranda JAL; Martins CDS; Barbosa MLL; Pimenta HB; Pimentel PVS; Teixeira CS; Scafuri MAS; Façanha SO; Barreto JEF; Carvalho PMM; Scafuri AG; Araújo JL; Rocha JA; Vieira IGP; Ricardo NMPS; da Silva Campelo M; Ribeiro MENP; de Castro Brito GA; Cerqueira GS
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
    Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.
    Kim HJ; Kim JH; Moon W; Park J; Park SJ; Song GA; Han SH; Lee JH
    Biol Pharm Bull; 2015; 38(2):179-83. PubMed ID: 25747976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl-peptidase-4 (DPP-4) inhibitor ameliorates 5-flurouracil induced intestinal mucositis.
    Lee JM; Yoo IK; Lee JM; Kim SH; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Chun HJ; Lee HS; Um SH; Kim CD
    BMC Cancer; 2019 Oct; 19(1):1016. PubMed ID: 31664952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model.
    Huang TY; Chu HC; Lin YL; Ho WH; Hou HS; Chao YC; Liao CL
    Biochem Biophys Res Commun; 2009 Nov; 389(4):634-9. PubMed ID: 19765544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alleviation of 5-fluorouracil-induced intestinal mucositis in rats by vitamin E via targeting oxidative stress and inflammatory markers.
    Al-Asmari AK; Khan AQ; Al-Asmari SA; Al-Rawi A; Al-Omani S
    J Complement Integr Med; 2016 Dec; 13(4):377-385. PubMed ID: 27682716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice.
    Araújo CV; Lazzarotto CR; Aquino CC; Figueiredo IL; Costa TB; Alves LA; Ribeiro RA; Bertolini LR; Lima AA; Brito GA; Oriá RB
    Braz J Med Biol Res; 2015 Jun; 48(6):493-501. PubMed ID: 25945744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model.
    Wu Z; Han X; Qin S; Zheng Q; Wang Z; Xiang D; Zhang J; Lu H; Wu M; Zhu S; Yu Y; Wang Y; Han W
    Biomed Pharmacother; 2010 Nov; 64(9):589-93. PubMed ID: 20888173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.